Lineweaver Wealth Advisors, LLC Abbott Laboratories Transaction History

Lineweaver Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $172,906 - $208,988	-1,694 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $342 - $417	3 Added 0.18%	1,694 $200,000
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $16,289 - $19,945	-141 Reduced 7.7%	1,691 $238,000
Q3 2021 Oct 22, 2021	BUY	$116.66 - $129.06 $5,949 - $6,582	51 Added 2.86%	1,832 $216,000
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $3,067 - $3,611	-29 Reduced 1.6%	1,781 $206,000
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $197,000 - $232,096	1,810 New	1,810 $217,000

3,265

1.31B

9.64M

8.27M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Lineweaver Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lineweaver Wealth Advisors, LLC with notifications on news.